Log in
Enquire now
‌

Aerska

RNA medicines developer to treat, delay, and prevent diseases of the brain.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
CEO
Jack O'Meara
Jack O'Meara
Country
United Kingdom
United Kingdom
Republic of Ireland
Republic of Ireland
Email Address
Founded Date
2025
Founder
‌
Stuart Milstein
‌
David Hardwicke
Jack O'Meara
Jack O'Meara
Headquarters
Dublin
Dublin
Industry
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
Biotechnology
Biotechnology
Investors
Ada Ventures
Ada Ventures
BlueYard Capital
BlueYard Capital
BACKED VC
BACKED VC
Speedinvest
Speedinvest
Norrsken VC
Norrsken VC
PsyMed Ventures
PsyMed Ventures
‌
Saras Capital
‌
Lingotto
‌
Kerna Ventures
‌
Age1
•••
Latest Funding Round Date
February 10, 2026
Latest Funding Round Amount (USD)
39,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/aerska
Location
London
London
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
60,000,000
Official Website
aerska.com

Find more companies like Aerska

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.